Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02405550

Ligand	Ligand name	Chain	PDB	Tanimoto
E20	1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE	A	1EVE	0.74
DRQ	(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL	A,B	2G5O	0.75
SDT	3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione	A,B	2ZI8	0.74
BM4	3-[(3R)-3-ethyl-1-{9-[(3S)-3-ethyl-3-(3-hydroxyphenyl)azepan-1-yl]nonyl}azepan-3-yl]phenol	X	2W6C	0.71
ESL	ESTRIOL	A	1X8V	0.71
ECS	2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE	A,B,C,D	2BW7	0.71
E3O	(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL	A	2J7Y	0.71
MA0	(1R)-6-HYDROXY-N-METHYL-N-[(1Z)-PROP-2-EN-1-YLIDENE]INDAN-1-AMINIUM	A,B	2C64	0.72
MUF	(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid	A,B	3BEJ	0.71
AAY	8-[2-((2S)-4-HYDROXY-1-{[5-(HYDROXYMETHYL)-6-METHOXY-2-NAPHTHYL]METHYL}-6-OXOPIPERIDIN-2-YL)ETHYL]-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL 2-METHYLBUTANOATE	A,B	1XDD	0.73
EQI	EQUILIN	A,B	1EQU	0.78
099	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	A,B	3HYG	0.72
EZT	(17BETA)-17-{(E)-2-[2-(TRIFLUOROMETHYL)PHENYL]VINYL}ESTRA-1(10),2,4-TRIENE-3,17-DIOL	A,B	2P15	0.72
TNC	4-DIMETHYLAMINO-1,10,11,12-TETRAHYDROXY-3-OXO-3,4,4A,5-TETRAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE	A,B	1N5Q	0.72
EST	ESTRADIOL	A,B	1GWR	0.73
EST	ESTRADIOL	A	1FDS	0.73
EST	ESTRADIOL	A,B,C	1G50	0.73
EST	ESTRADIOL	A,B,C,D,E,F	1ERE	0.73
EST	ESTRADIOL	A,B	1A52	0.73
EST	ESTRADIOL	A	1FDT	0.73
EST	ESTRADIOL	A	2OCF	0.73
EST	ESTRADIOL	A,B,C	1QKU	0.73
EST	ESTRADIOL	A,B,C,D,L	1E6W	0.73
EST	ESTRADIOL	A	1IOL	0.73
EST	ESTRADIOL	H	1JNN	0.73
EST	ESTRADIOL	B	1QKT	0.73
EST	ESTRADIOL	A	1FDW	0.73
EST	ESTRADIOL	A,B	1AQU	0.73
EST	ESTRADIOL	A	1LHU	0.73
EST	ESTRADIOL	A	1A27	0.73
EST	ESTRADIOL	L	1JGL	0.73
EST	ESTRADIOL	A,B,E,F	1PCG	0.73
EST	ESTRADIOL	A,B,C,D	1FDU	0.73
EST	ESTRADIOL	A	2J7X	0.73
EST	ESTRADIOL	A,B	2D06	0.73
RHP	(3R)-3-(PROP-2-YNYLAMINO)INDAN-5-OL	A,B	1S3E	0.71
3QC	(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE	A,B	2FME	0.77
PY9	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	A,B	3EKR	0.71
FBR	(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one	A	2GIU	0.71
EQU	EQUILENIN	A,B	1OGX	0.8
EQU	EQUILENIN	A,B,C,D,E,F	1QJG	0.8
EQU	EQUILENIN	A,B	1OH0	0.8
EQU	EQUILENIN	A	1W6Y	0.8
EQU	EQUILENIN	A,B	1CQS	0.8
EQU	EQUILENIN	A	1OGZ	0.8
EQU	EQUILENIN	A	1GS3	0.8
EQU	EQUILENIN	A	1OHO	0.8
HE7	4-{[(14beta,17alpha)-3-hydroxyestra-1,3,5(10)-trien-17-yl]oxy}-4-oxobutanoic acid	A,B,C,D	2Z77	0.71
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.84
EED	(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL	A,B	2QGT	0.71
2E3	(2E)-3-[4-hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]prop-2-enoic acid	A	3FUG	0.7
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQR	0.7
SAF	3-[(1S)-1-(DIMETHYLAMINO)ETHYL]PHENOL	A	1GQS	0.7
ESO	O3-PHOSPHONOESTRONE	B,C	1ESS	0.74
17M	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	A,B	2B1Z	0.74
OI1	3-(4-HYDROXYBENZYL)-2-[1-({[2-(4-HYDROXYPHENYL)ETHYL]AMINO}CARBONYL)BUTYL]-4-OXO-3,6,11,11A-TETRAHYDRO-4H-PYRAZINO[1,2-B]ISOQUINOLIN-2-IUM-1-OLATE	A,B	1Q9D	0.7